Valeant Providing Reporters With an Earnings Metric the SEC Ordered it to Stop Using Post author:Sam Post published:November 9, 2017 Post category:BioPharma Valeant is not the only company to recently push reporters to defy the SEC’s orders. Source: BioSpace You Might Also Like Pfizer Hosts Annual Meeting Of Shareholders April 26, 2017 Genentech Shows Off New Mid-Stage DME Data February 11, 2018 InspireMD Announces Distribution Agreement For CGuard EPS In Taiwan June 7, 2017
